December 6, 2017/Opinion

An Rx for Drug Prices: D.C. should drop the rhetoric and pass this one reform

In Newsweek op-ed, Chief Pharmacy Officer Scott Knoer calls for increased competition and expedited approval of generic/biosimilar drugs

Media Contact

Cleveland Clinic News Service | 216.444.0141

We’re available to shoot custom interviews & b-roll for media outlets upon request.

Media Downloads

CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.

images: 0

video: 0

audio: 0

text: 0

Scott Knoer, M.S., Pharm.D., Chief Pharmacy Officer

Politicians on all sides have talked about the need for drug price reform. Yet, despite the rhetoric, not a single federal law related to drug prices has passed.

It’s time to move past the empty promises and generate tangible results, Cleveland Clinic Pharmacy Officer Scott Knoer argues in a Newsweek op-ed.

While there are many potential solutions to the drug price problem, let’s focus on just one simple approach that is proven to be effective – increase competition in the marketplace by:

  • Passing the CREATES Act, which would allow generic versions of drugs to get to market faster after the patent protection ends.
  • Speeding up the approval and use of gneric and biosimilar drugs.

Read the entire piece at Newsweek.com: HOW TO REDUCE MEDICAL DRUG PRICES AT A STROKE

Latest from the Newsroom